Publications by authors named "Emily M Robinson"
Background and objective Athletics is the leading cause of pediatric concussion, and depression is a major comorbidity associated with concussion in the pediatric population. Prior studies have described the risk of depression after concussion in high school-, collegiate-, and elite-level athletes, but there is scarce data on younger athletes. Interpretation of existing research on the association of depression with concussions in youth athletes is complicated by diverse study designs, varying measures of depression, differing timelines for symptom development, and a lack of control groups.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to analyze trends in the incidence of positive surgical margins in patients with cT1-T2 oral cavity squamous cell carcinoma, assessing the factors influencing this condition from a large dataset.
- From 2004 to 2016, out of nearly 40,000 patients, 7.95% had positive surgical margins, but there was a trend of decreasing incidence over time, with notable factors like tumor stage and lymphovascular invasion contributing to higher odds of positive margins.
- The study concludes that treatment at high-volume and academic centers leads to lower rates of positive surgical margins, indicating the importance of treatment quality in outcomes for oral cavity cancer patients.
Craniofacial surgery continues to be a rapidly evolving field, due in part to interdisciplinary collaboration that has allowed for sharing of knowledge and methodologies, which has expanded greatly due to online journals and publications. The Journal of Craniofacial Surgery (JCS) is a highly regarded journal that has attracted attention for its mission to increase diversity and global representation in manuscript submissions and research publications. The purpose of this study is to provide an objective measurement of global participation in craniofacial research specifically as it pertains to the JCS.
View Article and Find Full Text PDFSubarachnoid haemorrhage (SAH) is a major contributor to the burden of stroke on society. Treatment options are limited and animal models of SAH do not always mimic key pathophysiological hallmarks of the disease, thus hindering development of new therapeutics. Inflammation is strongly associated with brain injury after SAH in animals and patients, and inhibition of the pro-inflammatory cytokine interleukin-1 (IL-1) represents a possible therapeutic target.
View Article and Find Full Text PDF